Kiora Pharma Inc Live Stock Price Today, Share Analysis and Chart

Name: Kiora Pharmaceuticals Inc: Is Infosys Ltd. worth buying?
Item: Kiora Pharmaceuticals Inc
Rating: 1.85816675
Author: Trendlyne DVM scores

about

Kiora Pharmaceuticals Inc is a clinical-stage biotechnology company developing and commercializing products for the treatment of orphan retinal diseases. As part of its development, KIO-301 is being studied for the treatment of retinitis pigmentosa, ...

2.58 -0.11 (-4.09%)

38.28% Fall from 52W High

32,519.6

XNAS Volume

XNAS 14 May, 2026 2:05 PM (EDT)

Not Eligible

Expensive Valuation

14.2 / 100

Technically Moderately Bullish

60.2 / 100

1Yr Price target upside is 365%

1 analysts

Kiora Pharma Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Kiora Pharma Inc Live Stock Price Today, Share Analysis and Chart

Kiora Pharmaceuticals Inc is a clinical-stage biotechnology company developing and commercializing products for the treatment of orphan retinal diseases. As part of its development, KIO-301 is being studied for the treatment of retinitis pigmentosa, ...

38.28% Fall from 52W High

SWOT Analysis

Kiora Pharma Inc Live Price Chart